Assessing liver function and hyperbilirubinemia in the newborn

Clinical Chemistry

Volumn 43, Issue 1, 1997, Pages 228-234

  Rosenthal, Philip ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

cholestasis; coagulation; hepatic synthesis

Indexed keywords

ALBUMIN; BILIRUBIN;

BILIRUBIN BLOOD LEVEL; BLOOD CLOTTING; CHOLESTASIS; CONFERENCE PAPER; FUNCTIONAL ASSESSMENT; GOOD LABORATORY PRACTICE; HUMAN; HYPERBILIRUBINEMIA; LIVER FUNCTION; NEWBORN MONITORING;

EID: 0031021370     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/43.1.228     Document Type: Conference Paper

References (61)

1. Albumin, P, S. In: Meites S, ed. Pediatric clinical chemistry reference (normal) values, 3rd ed. Washington, DC: AACC Press, 1989:37-43.
2. Park BK, Ellis EF. Changes in serum protein and immunoglobulin with age. In: Children are different. Columbus, OH: Ross Labs., 1978:185-90.
3. Lockitch G, Halstead AC, Albersheim S, MacCallum C, Quigley G. Age- and sex-specific pediatric reference intervals for biochemistry analyses as measured with the Ektachem-700 analyzer. Clin Chem 1988;34:1622-5.
4. Doumas BT, Watson A, Biggs HG. Albumin standards and the measurement of serum albumin with bromcresol green. Clin Chim Acta 1971;31:87-96.
5. Pinnell AE, Northam BE. New automated dye-binding method for serum albumin determination with bromcresol purple. Clin Chem 1978:24:80-6.
6. Violi F, Ferro D, Quintarelli C, et al. Clotting abnormalities in chronic liver disease. Dig Dis 1992:10:162-72.
7. Spector I, Corn M. Laboratory tests of hemostasis: the relation to hemorrhage in liver disease. Arch Intern Med 1967:119:577-82.
8. Andrew M, Paes B, Johnston M. Development of the hemostatic system in the neonate and young infant. Am J Pediatr Hematol Oncol 1990:12:95-104.
9. Andrew M, Paes B, Milner R, et al. The development of the human coagulation system in the fullterm infant. Blood 1987;72:165-72.
10. Andrew M, Paes B, Milner R, et al. Development of the coagulation system in the healthy preterm infant. Blood 1988:72:1651-7.
11. Walser M. Urea cycle disorders and other hereditary hyperammonemic syndromes. In: Stanbury JB, Wyngaarden JB, Fredrickson DS, Goldstein JL, Brown MS, eds. The metabolic basis of inherited disease, 5th ed. New York: McGraw-Hill, 1983:402-38.
12. Conn HO, Lieberthal MM. Blood ammonia determination. In: Conn HO, Lieberthal MM, eds. The hepatic coma syndromes and lactulose. Baltimore: Williams & Wilkins, 1978:73-6.
13. Ammonia. In: Meites S, ed. Pediatric clinical chemistry reference (normal) values, 3rd ed. Washington, DC: AACC Press, 1989: 52-3.
14. Ammonia. In: Soldin SJ, Hicks JM, eds. Pediatric reference ranges. Washington, DC: AACC Press, 1995:28.
15. Ellis G, Goldberg D, Spooner FM. Serum enzyme tests in diseases of the liver and biliary tree. Am J Clin Pathol 1978;70:248-58.
16. Wrobleski F. The clinical significance of transaminase activities in serum. Am J Med 1959:27:911-23.
17. Zimmerman HJ, West M. Serum enzyme levels in the diagnosis of hepatic disease. Am J Gastroenterol 1963;40:837-44.
18. Treem WR. Persistent elevation of transaminases as the presenting finding in an adolescent with an unsuspected muscle glycogenosis. Clin Pediatr 1987:26:605-7.
19. Morse RP, Rosman NP. Diagnosis of occult muscular dystrophy: importance of the "chance" finding of elevated serum aminotransferase activities. J Pediatr 1993:122:254-6.
20. Rosenthal P, Haight M. Aminotransferase as a prognostic index in infants with liver disease. Clin Chem 1990:36:346-8.
21. Alanine aminotransferase (ALT), P, S (EC 2. 6.1.2), aspartate aminotransferase, AST, P, S (EC 2.6.1.1). In: Meites S, ed. Pediatric clinical chemistry reference (normal) values, 3rd ed. Washington, DC: AACC Press, 1989:33-37, 60-66.
22. Cheng MH, Lipsey AI, Blanco V, Wong HT, Spiro SH. Microchemical analysis for 13 constituents of plasma from healthy children. Clin Chem 1979:25:692-8.
23. Diehl AM, Potter J, Boitnott J, et al. Relationship between pyridoxal 5′-phosphate deficiency and aminotransferase levels in alcoholic hepatitis. Gastroenterology 1984;86:632-6.
24. Cohen GA, Goffinet JA, Donabedian RK, et al. Observations on decreased serum glutamic oxaloacetic transaminase (SGOT) activity in azotemic patients. Ann Intern Med 1976:84:275-80.
25. Warnock LG, Stone WJ, Wagner C. Decreased aspartate amino-transferase ("SGOT") activity in serum of uremic patients. Clin Chem 1974;20:1213-6.
26. Lactate dehydrogenase (EC 1. 1.1.27). In: Meites S, ed. Pediatric clinical chemistry reference (normal) values, 3rd ed. Washington, DC: AACC Press, 1989:175-82.
27. Lactate dehydrogenase (LDH). In: Soldin SJ, Hicks JM, eds. Pediatric reference ranges. Washington, DC: AACC Press, 1995: 95.
28. Clarke LC, Beck E. Plasma "alkaline" phosphatase activity. I. Normative data for growing children. J Pediatr 1950:36:335-41.
29. Kattwinkel J, Taussig LM, Statland BE, et al. The effects of age on alkaline phosphatase and other serologic liver function tests in normal subjects and patients with cystic fibrosis. J Pediatr 1973; 82:234-42.
30. Salz JL, Daum F, Cohen MI. Serum alkaline phosphatase activity during adolescence. J Pediatr 1973:82:536-7.
31. Alkaline phosphatase (ALP). In: Soldin SJ, Hicks JM, eds. Pediatric reference ranges. Washington, DC: AACC Press, 1995:5.
32. Goldberg DM, Martin JV. Role of garnma-glutamyl transpeptidase activity in the diagnosis of hepatobiliary disease. Digestion 1975; 12:232-46.
33. Maggiore G, Bernard O, Hadchouel M, et al. Diagnostic value of serum gamma-glutamyl transpeptidase activity in liver diseases in children. J Pediatr Gastroenterol Nutr 1991:12:21-6.
34. Rosalki SB, Tarlow D, Rau D. Plasma gamma-glutamyl transpeptidase elevation in patients receiving enzyme-inducing drugs. Lancet 1971:2:376-7.
35. Deutsch J, Fritsch G, Golles J, et al. Effects of anticonvulsive drugs on the activity of gamma-glutamyltransferase and aminotransferases in serum. J Pediatr Gastroenterol Nutr 1986;5: 542-8.
36. Priolisi A, Didata M, Fazio M, et al. Variations of the serum gamma-glutamyl transpeptidase activity in full-term and pre-term babies during their first two weeks of life. Minerva Pediatr 1980:32:291-6.
37. Shore GM, Hoberman L, Dowdey ABC, et al. Serum gamma-glutamyl transpeptidase activity in normal children. Am J Clin Pathol 1975:63:245-50.
38. Knight JA, Haymond RE. Gamma-glutamyltransferase and alkaline phosphatase activities compared in serum of normal children and children with liver disease. Clin Chem 1981:27:48-51.
39. Gamma-glutamyltransferase (GGT). In. Soldin SJ, Hicks JM, eds. Pediatric reference ranges. Washington, DC: AACC Press, 1995: 68.
40. Newman TB, Klebanoff MA. Peak serum bilirubin in normal-sized infants and neurodevelopmental outcome at age 7: a closer look at the collaborative perinatal study. Pediatrics 1993:92:651-7.
41. Newman TB, Maisels MJ. Does hyperbilirubinemia damage the brain of healthy newborn infants? Clin Perinatol 1990:17:331-58.
42. Newman TB, Maisels MJ. Evaluation and treatment of jaundice in the term infant: a kinder, gentler approach. Pediatrics 1992;89: 809-18.
43. Seidman DS, Paz I, Stevenson DK, Laor A, Danon YL, Gale R. Neonatal hyperbilirubinemia and physical and cognitive performance at 17 years of age. Pediatrics 1991;88:828-33.
44. American Academy of Pediatrics, Practice Parameter: management of hyperbilirubinemia in the healthy term newborn. Pediatrics 1994;94:558-62.
45. Thaler MM. Jaundice in the newborn: algorithmic diagnosis of conjugated and unconjugated hyperbilirubinemia. JAMA 1977; 237:58-62.
46. Gartner LM. Management of jaundice in the well baby. Pediatrics 1992;89:826-7.
47. Heggi T, Hiatt IM, Indyk L. Transcutaneous bilirubinometry. I. Correlations in term infants J Pediatr 1981:98:454-7.
48. Martinez JC, Maisels MJ, Otheguy L, et al. Hyperbilirubinemia in the breast-fed newborn: controlled trial of four interventions. Pediatrics 1993:91:470-3.
49. Lott JA, Doumas BT. "Direct" and total bilirubin tests: contemporary problems. Clin Chem 1993;39:641-7.
50. Vreman HJ, Verter J, Oh W, Fanaroff M, Wright LL, Lemons JA, et al. Interlaboratory variability of bilirubin measurements. Clin Chem 1996;42:869-73.
51. Weiss JS, Gautam A, Lauff JJ, et al. The clinical importance of a protein-bound fraction of serum bilirubin in patients with hyperbilirubinemia. N Engl J Med 1983;309:147-50.
52. Brett EM, Hicks JM, Powers DM, Rand RN. Delta bilirubin in serum of pediatric patients: correlations with age and disease. Clin Chem 1984;30:1561-4.
53. Rosenthal P, Blanckaert N, Kabra PM, Thaler MM. Formation of bilirubin conjugates in human newborns. Pediatr Res 1986;20: 947-50.
54. Rosenthal P, Henton D, Felber S, Sinatra FR. Distribution of serum bilirubin conjugates in pediatric hepatobiliary diseases. J Pediatr 1987;110:201-5.
55. Brown AK, Seidman DS, Stevenson DK. Jaundice in healthy term neonates: do we need new action levels or new approaches? Pediatrics 1992;89:827-8.
56. Cashore WJ. Hyperbilirubinemia: should we adapt a new standard of care? Pediatrics 1992:89:824-6.
57. Johnson L. Yet another expert opinion on bilirubin toxicity! Pediatrics 1992;89:829-30.
58. Merenstein GB. "New" bilirubin recommendations questioned. Pediatrics 1992;89:822-3.
59. Watcho JF, Oski FA. Bilirubin 20 mg/dl = vigintiphobia. Pediatrics 1983;71:660-3.
60. Wennberg RP. Bilirubin recommendations present problems: new guidelines simplistic and untested. Pediatrics 1992;89:821-2.
61. Maisels MJ. Jaundice. In: Avery GB, ed. Neonatology: pathophysiology and management of the newborn, 4th ed. Philadelphia: J.B. Lippincott Co., 1994:630-725.